Ranganath Nischal, Yetmar Zachary A, Saleh Omar Abu, Tande Aaron J, Shah Aditya S
Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Transpl Infect Dis. 2024 Feb;26(1):e14203. doi: 10.1111/tid.14203. Epub 2023 Nov 27.
Gram-negative bacillary bloodstream infection (GN-BSI) is a frequent clinical challenge among immunocompromised hosts and is associated with a high mortality. The utility of follow-up blood cultures (FUBCs) for GN-BSI in this population, particularly in the setting of neutropenia, is poorly defined.
We conducted a single-center, retrospective cohort study between the period of July 2018 and April 2022 to investigate the utility of FUBCs and delineate risk factors for positive cultures among neutropenic patients with monomicrobial GN-BSI. Univariate logistic regression was performed to assess risk factors associated with positive FUBCs.
Of 206 patients, 98% had FUBCs performed, and 9% were positive. Risk factors for positive FUBCs included multidrug-resistant GN infection (OR 3.26; 95% confidence interval [CI] 1.22-8.72) and vascular catheter source (OR 4.82; CI 1.76-13.17). Among patients lacking these risk factors, the prevalence of positive FUBCs was low (2.8%) and the negative predictive value was 92%. Those with positive and negative FUBCs had similar rates of all-cause mortality (16.7% vs. 16.6%; p = .942) and microbiologic relapse (11.1% vs. 6.0%; p = .401) within 90-days of treatment completion. However, positive FUBCs were associated with prolonged hospitalization and longer duration of antimicrobial therapy.
Positive FUBCs were infrequent in neutropenic patients with GN-BSI, and their occurrence did not significantly impact mortality or microbiologic relapse. Risk factors for positive FUBCs included multidrug resistant Gram-negative infection and vascular catheter source. Prospective studies will be necessary to elucidate the benefits and risks of FUBCs when managing GN-BSI in patients with underlying immune compromise.
革兰氏阴性杆菌血流感染(GN-BSI)在免疫功能低下的宿主中是常见的临床挑战,且与高死亡率相关。对于该人群中的GN-BSI,尤其是在中性粒细胞减少的情况下,后续血培养(FUBC)的作用尚不明确。
我们在2018年7月至2022年4月期间进行了一项单中心回顾性队列研究,以调查FUBC的作用,并确定单微生物GN-BSI中性粒细胞减少患者血培养阳性的危险因素。采用单因素逻辑回归分析评估与FUBC阳性相关的危险因素。
206例患者中,98%进行了FUBC,9%为阳性。FUBC阳性的危险因素包括多重耐药GN感染(比值比[OR]3.26;95%置信区间[CI]1.22-8.72)和血管导管来源(OR 4.82;CI 1.76-13.17)。在缺乏这些危险因素的患者中,FUBC阳性率较低(2.8%),阴性预测值为92%。FUBC阳性和阴性的患者在治疗完成后90天内的全因死亡率(16.7%对16.6%;p = 0.942)和微生物学复发率(11.1%对6.0%;p = 0.401)相似。然而,FUBC阳性与住院时间延长和抗菌治疗持续时间延长有关。
GN-BSI中性粒细胞减少患者中FUBC阳性并不常见,其出现对死亡率或微生物学复发没有显著影响。FUBC阳性的危险因素包括多重耐药革兰氏阴性感染和血管导管来源。有必要进行前瞻性研究,以阐明在管理有潜在免疫功能损害的患者的GN-BSI时FUBC的益处和风险。